polypil drug medicin term polypil ha coin refer medic combin activ ingredi import controversi articl bmj wald law propos concept polypil combin medic alreadi market decad order reduc cardiovascular diseas wald law innov analyt approach combin numer result sever high qualiti metaanalys individu impact medic produc estim overal combin propos polypil morbid mortal polypil idea physic pill increas adher complianc reduc number pill person ha novel methodolog approach sens numer metaanalysi metaanalys estim combin impact sever medic intervent sinc mani articl written propos sort polypil methodolog wald law promis polypil diabet potenti prediabet kuehn polypil slash diabet risk jama wald law polypil strategi reduc cardiovascular diseas paper strategi reduc cardiovascular diseas publish british medic journal june wald law postul combin well cheap medic pill polypil particularli treatment cardiovascular diseas statist model widespread polypil reduc mortal heart diseas stroke treatment potenti cheap side perhap recipi wa base data mani trial relat individu compon howev actual patient real benefit combin medic compar infer benefit calcul overwhelm evid favor polypil individu compon concept well recognis reduc blood pressur cholesterol low dose aspirin will help prevent heart diseas stroke test wald law polypil recommend addit polypil current avail india ani gp current prescrib compon polypil separ herhi patient unfortun ingredi polypil patent sinc thi polypil quit cheap estim bmj rapid respons pound year littl financi incent pharmaceut compani pay high cost clinic trial natur howev larg insur nation healthcar system consider financi incent pay trial wald law ha unusu novel perspect everyon age pill medic manag issu irrespect individu risk idea reduc blood pressur cholesterol patient popul will benefit basic polypil default medic peopl compar risk current individu cardiovascular risk calcul base year longitudin studi popul framingham massachusett framingham heart studi polypil popul base approach manag concept normal treatment threshold becom relev popul base approach diseas controltradit approach ha treat onli risk threshold reach paradox individu mayb reach tradit threshold benefit will accru reduct blood pressur cholesterol thi becaus slide scale risk concept abnorm side correspond high risk requir treatment normal side low risk requir treatment scrutini doctor will treat popul risk individu risk factor threshold current mainstream practic everyon wa polypil averag blood pressur cholesterol level popul fall thu reduc overal popul risk polypil blood pressur medic low dose diuret bendroflumethiazid betablock atenolol ace inhibitor enalapril thi combin statin simvastatin aspirin dose folic acid folic acid ha reduc level homocystein blood anoth risk factor heart diseas plan coordin intern forum discuss concept polypil polypil diabet syndrom diabet particularli type ii diabet major caus morbid mortal diabet contribut substanti cardiovascular risk unfortun ingredi wald law origin polypil advis patient diabet exampl betablock lead weight gain thiazid diuret polypil diabet includ statin reduc ldl cholesterol antiinflamatori properti ace inhibitor blood pressur control protect kidney aspirin anti platelet antiinflamatori properti metformin excel medic diabet associ weight loss mani peopl overweight diabet mani addit peopl pre diabet benefit activ intervent overal peopl diabet prediabet high cholesterol or high blood pressur overweight consid metabol syndrom benefit substanti diabet polypil perhap polypil strategi becom wide adopt peopl normal bodi mass waist circumfer will wald law polypil obes substanti overweight will diabet syndrom polypil cost wald law analysi correct major cost save product gain polypil approach similarli diabet syndrom polypil estim save billion dollar importantli tremend human cost devast underappreci chronic diseas substanti reduc person ha stroke ruin qualiti life place major burden carer kidney failur dialysi common endstag diabet devast health care system major insur kaiser permanent veri well financi human level fulli test introduc polypil sourc resist medic expertis simplic treatment polypil strategi work larg percentag patient popul threaten expert specialist stand lose financi doubt expert delight human benefit probabl endors despit ani person financi hardship thi caus polypil simpl offtherack default treatment reduc sens control exercis expertis prescrib individu tailor medic regimen unfortun individu tailor approach expens difficult time consum access lifestyl modif punish sinner larg cohort health profession advoc lifestyl modif true smoke exercis hour day eat healthi low fat diet time dramat reduc cardiovascular risk unfortun peopl realiti find thi difficult unpleas invas intrus adher therefor realiti achiev sustain gain furthermor increas evid individu healthli lifestyl medic statin reduc cardiovascular risk doubt best remind patient benefit lifestyl modif encourag pursu thi doe justifi delay potenti highli benefici medic polypil practic peopl abov will abl sustain suffici lifestyl modif will benefit medic polypil sens overli strong devot lifestyl modif approach impli sinner unabl unwil dramat alter lifestyl habit expect suffer noncompli thi doe appropri deal fellow human ourselv sometim flaw weak deserv prevent care natur individu prefer tri lifestyl modif approach encourag remind mani peopl succeed medic treatment avail cardiovascular diseas diabet asymptomat substanti irrevers damag ha thi dogmat lifestyl modif approach particularli danger becaus drive patient treatment satir wald law approach ha gener substanti controversi critic origin contribut thi regard form satir articl quit well written propos tongu cheek mixtur mani differ healthi food type author refer thi polym refer wald law strategi reduc cardiovascular diseas british medic journal june kuehn polypil slash diabet risk jama test start pill lengthen live tablet aim cut heart attack stroke risk fourinon drug sold month sarah boseley health editor guardian monday septemb